⏳ Fetching live dividend data...
Home › Calculator › IRIX Dividend Calculator 2026
IRIDEX Corporation · NASDAQ
Price: $1.01 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in IRIX → $27.52M in 10 years · $681,408.37/month
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IRIX position with:
Real after-tax yield depends on where you live and how you hold IRIX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 198.02% | 195.22% | $19,802 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 168.32% | 165.52% | $16,832 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 158.42% | 155.62% | $15,842 / yr |
| 🇬🇧 UK ISA | 0% | 198.02% | 195.22% | $19,802 / yr |
| 🇬🇧 UK Taxable | 8.75% | 180.69% | 177.89% | $18,069 / yr |
| 🇨🇦 TFSA | 0% | 198.02% | 195.22% | $19,802 / yr |
| 🇨🇦 CA Taxable | 25% | 148.52% | 145.72% | $14,852 / yr |
| 🇦🇺 Super (pension) | 15% | 168.32% | 165.52% | $16,832 / yr |
| 🇦🇺 AU Taxable | 30% | 138.61% | 135.81% | $13,861 / yr |
| 🇩🇪 DE Taxable | 26.375% | 145.79% | 142.99% | $14,579 / yr |
| 🇫🇷 FR Taxable | 30% | 138.61% | 135.81% | $13,861 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IRIX pays quarterly — 4 times per year. Next ex-div: TBD.
How IRIX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IRIX sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-06-08 | 2,400 | $1.12 | $2.7K | ||
| Buy | 2026-06-05 | 2,521 | $1.15 | $2.9K | ||
| Buy | 2026-06-03 | 2,400 | $1.17 | $2.8K | ||
| F-InKind | 2026-05-26 | 19,233 | $1.01 | $19.4K | ||
| Buy | 2026-05-26 | 5,004 | $1.00 | $5.0K | ||
| J-Other | 2026-04-01 | 87,949 | — | — | ||
| Buy | 2026-03-06 | 1,110 | $1.26 | $1.4K | ||
| Buy | 2026-02-17 | 1,200 | $1.31 | $1.6K | ||
| Buy | 2026-02-17 | 1,000 | $1.37 | $1.4K | ||
| Buy | 2026-02-12 | 1,500 | $1.43 | $2.1K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IRIX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →